West Pharmaceutical Services (NYSE:WST).
Raymond James & Associates reports that it lowered its stake in West Pharmaceutical Services by 0.8% in the quarter ending 09/30/2017. Its position was worth $6,711,000 an increase of 1.1% according to the filing.
Here are some institutional investors who have increased or decreased their stake in (WST). Ubs Asset Management Americas Inc grew its investment by buying 784 shares an increase of 2,010.3% in the quarter. Ubs Asset Management Americas Inc owns 823 shares valued at $79,222,000. The total value of its holdings increased 2,049.3%. As of quarter end Eagle Asset Management Inc had disposed of a total of 208,078 shares trimming its holdings by 18.9%. The value of the investment in West Pharmaceutical Services went from $103,938,000 to $86,098,000 a change of $17,840,000 for the reporting period.
Commonwealth Of Pennsylvania Public School Empls Retrmt SYS expanded its ownership by buying 60 shares an increase of 0.6% as of 09/30/2017. Commonwealth Of Pennsylvania Public School Empls Retrmt SYS currently owns 10,795 shares with a value of $1,039,000. The value of the position overall is up by 2.4%.
Wells Fargo & Company raised the price target on October 27 changing the forecast from $105.00 to $112.00 with a “Outperform” recommendation.
Equity analyst Stephens updated coverage of WST with a rating of “Equal Weight”.
The company is down by 1.39% percent from yesterday’s close. West Pharmaceutical Services’s P/E ratio is 39.59 and the market cap of the company is 7.38B. In the latest earnings report the EPS was $2.51 with 74.25M shares currently outstanding.
Short traders are more bearish on shares of the company if you put credence in the motion in short interest. The company recorded a rise in short interest between September 29, 2017 and October 13, 2017 of 1.42%. Short shares grew from 2,027,101 to 2,055,836 over that period. The short-interest ratio increased to 8.0 and the short interest percentage is 0.03% as of October 13.